— Published date: 7/28/2026 Value Proposition: Synergistic combination of intratumoral oncolytic therapy and MEK inhibition for treating metastatic melanoma. Technology Description Researchers at Washington University in St. Louis have developed a highly effective combination therapy using two …
— Published date: 7/22/2026 Value Proposition: New process that tackles two RA signaling pathways to improve treatment of various diseases. Technology Description Researchers at Washington University in St. Louis have uncovered an antagonistic interaction between estrogen and retinoic acid (RA) …
— Published date: 7/21/2026 Value Proposition: Approach to modulating the stiffness of PEDOT:PSS within an electrolyte solution through the application of mild and short voltage. Technology Description Researchers at Washington University in St. Louis have developed a unique, dynamic platform w…
— Published date: 7/16/2026 Value Proposition: A miniaturized implantable electrochemical platform for continuous monitoring of metabolic biomarkers in deep tissue. Technology Description Researchers at Washington University in St. Louis have developed a minimally invasive, multi-analyte, electr…
— Published date: 7/15/2026 Value Proposition: 3D printed bioelectronic scaffolds for temporal monitoring of cytotoxicity in 3D cancer models. Technology Description Researchers at Washington University in St. Louis have developed a 3D printed bioelectronic scaffold capable of supporting dense c…
— Published Date: 7/7/2026 Value Proposition: This invention introduces a mucosal vaccine that can provide immunity against multiple Sarbecoviruses. Technology Description Researchers at Washington University in St. Louis have developed an adenoviral-vectored vaccine that can induce broad immunity…
— Published Date: 7/7/2026 Value Proposition: Eye occluder glasses that provide a steady, hands-free opportunity to efficiently measure visual acuity. Technology Description Researchers at Washington University in St. Louis have developed a pair of eye occluder glasses with a pinhole that can b…
— Published date: 7/7/2026 Value Proposition: Novel covalent dimerization of UvrD helicase that enhances DNA unwinding processivity and isothermal polymerase chain reaction. Technology Description Researchers at Washington University in St. Louis have developed a modified Superfamily 1A helicase …
— Published date: 6/13/2026 Value Proposition: Novel glucagon regulator and therapeutic for diabetes Technology Description Researchers from the laboratory of Dr. David Piston at Washington University have discovered and isolated a peptide-based treatment from brown adipose tissue that normal…
— Published date: 6/9/2026 Value Proposition: New medical device that allows for safe stent graft removal without damaging surround tissues. Technology Description Researchers at Washington University in St. Louis have developed an innovative medical device specifically designed to facilitate the…
— Published date: 6/4/2026 Value Proposition: Brain-computer interface for monitoring and modulating neural states based on saccade-related neural dynamics. Technology Description Researchers at Washington University in St. Louis have developed a neurotechnology platform that monitors and modulat…
— Published date: 6/4/2026 Value Proposition: Novel surgical cutting tool that allows for more precise annular incisions during spinal surgeries. Technology Description Researchers at Washington University in St. Louis have developed a shielded surgical cutting instrument named the “Lysot…
— Published date: 6/4/2026 Value Proposition: Method allowing for more effective delivery of therapeutic agents into the intima and media layers of a blood vessel. Technology Description Researchers at Washington University in St. Louis have developed a new method for utilizing electroporation an…
— Published date: 6/3/2026 Value Proposition: Using CLCA1 VWA to specifically potentiate TMEM16A to enhance mucociliary transport in cystic fibrosis and other mucus obstructive diseases. Technology Description Researchers at Washington University in St. Louis have developed a potentiator, CLCA1 …
— Published date: 6/2/2026 Value Proposition: First-in-class antisense oligonucleotide (ASO) therapy selectively lowering ACOX1 to enable disease-modifying treatment of Mitchell Syndrome and unlocking a metabolic shift facilitating weight loss. Technology Description: Mitchell Syndrome is an u…
— Published date: 6/2/2026 Value Proposition: VLA4 inhibitors that significantly mobilize hematopoietic stem cells from bone marrow. Technology Description Researchers at Washington University in St. Louis have developed novel VLA4 inhibitors for mobilizing hematopoietic stem cells in peripheral …
— Published date: 6/2/2026 Value proposition: CAR-engineered cDC1 cells (syngeneic or allogeneic) that stably express a proprietary, modular chimeric antigen receptor and demonstrate strong in vivo efficacy against solid tumors, including immunologically ‘cold’ tumors. Technology Desc…
— Published date: 5/30/2026 Value Proposition: Doppler-derived parameter that can account for the preload condition dependency of diastolic function in acute heart failure. Technology Description Researchers at Washington University in St. Louis have developed and validated the Dynamic Diastolic L…
— Published date: 5/30/2026 Value Proposition: CAR-engineered cDC1 cells (syngeneic or allogeneic) that stably express a proprietary, modular chimeric antigen receptor and demonstrate strong in vivo efficacy against solid tumors, including immunologically ‘cold’ tumors. Technology Descr…
— Published date: 5/29/2026 Value Proposition: Urine-based biomarkers that can be used for early detection and diagnosis of kidney disease non-invasively. Technology Description Researchers at Washington University in St. Louis have identified three sensitive, urine-based biomarkers of kidney di…
